Your Article Summary
Cardiac Cell Repair Therapy: A Clinical Perspective
Mayo Clinic Proceedings, 10/12/09
Gersh BJ et al. – An interdisciplinary effort across the scientific and clinical community within academia, biotechnology, and government will drive the successful realization of this next generation of therapeutic agents for the “broken” heart.
Bernard J. Gersh, 10/12/09
| The translation of cardiac cell repair therapy into the clinical arena is indeed an intriguing but challenging objective. The field is still in it,s relative infancy and the road of exploration will lengthy and difficult. Expectations need to be tempered and realistic but this is the focus of a massive international research effort and rapid progress is being made. Clinicians should become familiar with the terminology and concepts and follow with interest even if from a distance If cardiac cell repair therapy fulfills it,s potential , this could revolutionize the treatment of heart disease and we can expect that the rate of translational research will accelerate, even if it,s role as a routine part of the clinical armamentarium is a long way off |
Related Articles
The role of MRI in peripartum cardiomyopathy
International Journal of Cardiology, 10/15/09
Relevance Score: 89%
Defects in long chain fatty acid oxidation presenting as severe cardiomyopathy and cardiogenic shock in infancy
Cardiology in the Young, 10/21/09
Relevance Score: 88%
Celiac Disease Associated with Dilated Cardiomyopathy
Southern Medical Journal, 10/07/09
Relevance Score: 88%
Can peripartum cardiomyopathy be familial
International Journal of Cardiology, 10/14/09
Relevance Score: 87%
Cardiac insulin-like growth factor-1 and cyclins gene expression in canine models of ischemic or overpacing cardiomyopathy
BMC Cardiovascular Disorders, 10/14/09
Relevance Score: 87%
Today in Biotechnology...keeping you current
Receive free subspecialty "5-minute updates" via email
ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use the Companys TAP Technology
ImmunoGen, Inc., 11/20/09
Expanding The Biopharmaceutical Industry's Involvement In Fighting Neglected Diseases
Health Affairs, 11/19/09
A Business Plan To Help The 'Global South' In Its Fight Against Neglected Diseases
Health Affairs, 11/19/09
Article Search
Sponsor


See Latest Articles


